News
ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (“CDMO”) focused exclusively on the design, derisking, and GMP manufacture of viral vectors for ...
Prellis has generated 300 human antibodies for treatment and prevention of COVID-19; reduces time to produce candidate antibodies to under a month.
LONDON & NEW YORK, December 16, 2024--ViroCell Biologics ("ViroCell" or the "Company"), a cell and gene therapy ("CGT") contract development and manufacturing organization ("CDMO") specializing in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback